Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FOLFOXIRI Regimen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT05427669
What this trial is testing

Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)

Who this might be right for
Colorectal Cancer
Yanhong Deng 340
Testing effectiveness (Phase 2)UnknownNCT02591667
What this trial is testing

Histopathological Response to FOLFOXIRI + Bevacizumab in Peritoneal Metastasis From Colorectal Cancer

Who this might be right for
Colorectal CancerPeritoneal Metastasis
Medical University of Vienna 30
Testing effectiveness (Phase 2)Study completedNCT07024537
What this trial is testing

FOLFOXIRI-based HAIC Combined With Fuquintinib as Late-line Treatment in Patients With CRLM：A Phase 2 Single-Arm Clinical Trial

Who this might be right for
Colorectal Neoplasms
Meng Qiu 44
Testing effectiveness (Phase 2)Temporarily pausedNCT05062889
What this trial is testing

Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients

Who this might be right for
Stage II Colon CancerStage III Colon CancerHER2-positive Colon Cancer+1 more
Gruppo Oncologico del Nord-Ovest 477
Not applicableUnknownNCT05362825
What this trial is testing

Surgery Outcome Treated by Neo-adjuvant Combination of Oxaliplatin, Irinotecan, Folinic Acid and Fluorouracil (FOLFOXIRI) Regimen in Synchronous Liver Limited Metastasis Colorectal Cancer

Who this might be right for
Liver Metastasis Colon CancerSynchronous Neoplasm
Cho Ray Hospital 89
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Testing effectiveness (Phase 2)Study completedNCT02350530
What this trial is testing

FOLFOXIRI With or Without Bevacizumab as First-line Treatment for Unresectable Liver-only Metastatic Colorectal Cancer Patients With RAS Mutation-type

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 138
Testing effectiveness (Phase 2)Temporarily pausedNCT05358704
What this trial is testing

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

Who this might be right for
Cancer of Rectum
Rutgers, The State University of New Jersey 38
Testing effectiveness (Phase 2)Looking for participantsNCT03401294
What this trial is testing

Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
University of Saskatchewan 32
Testing effectiveness (Phase 2)UnknownNCT06575127
What this trial is testing

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

Who this might be right for
Neoplasm MalignantColon Cancer Stage 4
Al-Azhar University 60
Testing effectiveness (Phase 2)Study completedNCT01163396
What this trial is testing

First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Gruppo Oncologico del Nord-Ovest 57
Not applicableStudy completedNCT01437618
What this trial is testing

First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Azienda Ospedaliero, Universitaria Pisana 15
Testing effectiveness (Phase 2)Study completedNCT01226719
What this trial is testing

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Who this might be right for
Colorectal Cancer
SCRI Development Innovations, LLC 15
Testing effectiveness (Phase 2)Study completedNCT02063529
What this trial is testing

FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 101
Testing effectiveness (Phase 2)Study completedNCT03443661
What this trial is testing

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Aiping Zhou 50
Testing effectiveness (Phase 2)Study completedNCT03721653
What this trial is testing

FOLFOXIRI + Bev + Atezo vs FOLFOXIRI + Bev as First-line Treatment of Unresectable Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 218
Large-scale testing (Phase 3)Not Yet RecruitingNCT07277842
What this trial is testing

PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

Who this might be right for
Locally Advanced Low Rectal AdenocarcinomapMMR (Microsatellite Stable Rectal Cancer)
Sun Yat-sen University 382
Testing effectiveness (Phase 2)UnknownNCT01494363
What this trial is testing

Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Soon Chun Hyang University 53
Testing effectiveness (Phase 2)Study completedNCT02246049
What this trial is testing

A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC

Who this might be right for
Colorectal Neoplasms
EPS Corporation 69
Testing effectiveness (Phase 2)UnknownNCT05018182
What this trial is testing

FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer

Who this might be right for
High-risk Locally Advanced Colorectal CancerNeoadjuvant ChemotherapyFOLFOXIRI Regimen
West China Hospital 69
Next Page